Peer-reviewed journal articles featuring Fortrea oncologists published 2020-2024
Related insights
More from our insights
Peer-reviewed journal articles featuring Fortrea oncologists published 2020-2024
Télécharger la ressource
San Francisco Bay Area biotech advances Phase I-II cancer immunotherapy trial with Fortrea
A San Francisco Bay Area biotech company approached Fortrea to manage a Phase I-II clinical trial evaluating a personalized, neoantigen-based vaccine.
Téléchargez l'étude de cas
Future directions in liquid biopsy technology
Recent technological advancements have dramatically improved the sensitivity of liquid biopsies, enabling earlier diagnosis, precise treatment selection and enhanced disease monitoring.
En savoir plus
Guiding a biotech’s development of an immunotherapy cancer treatment with 'out-of-the-box' thinking
This case study delves into how Fortrea helped guide a sponsor's immunotherapy cancer treatment with out-of-the-box thinking.
Téléchargez l'étude de cas
Aligning core values to for a tripartite partnership and advance an oncology program
A partnership model matched the sponsor’s needs and enabled transparency in each interaction.
Téléchargez l'étude de cas
Our latest oncology publications
Our collaborative approach can result in co-authorship of peer-reviewed journal articles based on projects we’ve supported.
Télécharger la ressource
Accélérer le développement clinique grâce à la conception, à la diversité et à la digitalisation en oncologie et dans d'autres domaines
Regarder le webinaire
Clinical Development in the Precision Medicine Era
The era of precision medicine is reshaping oncology trials, offering unprecedented opportunities to tailor treatments to individual genetic profiles. This transformation brings challenges in trial design and execution, and companies must adapt their clinical development strategies to stay ahead.
En savoir plus
It is never too early to start a strategic plan for oncology product development in the APAC region
In oncology, a goal-oriented, holistic strategic plan is crucial, even in the earliest phases of product development.
En savoir plus
A Scientific Journey in the Midst of the Russia/Ukraine Conflict
Fortrea's efforts in continuing scientific research and clinical trials amidst the challenges posed by the Russia-Ukraine conflict.
En savoir plus